1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01-04-20, NCT00243867
|
|
2.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: THERADEX-P01-00-03, PROTARGA-P01-00-03, VMRC-8770, NCT00024375
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: THERADEX-P01-00-07, CCF-IRB-4046, PROTARGA-P01-00-07, NCT00024388
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: THERADEX-P01-00-01, ABCCC-010505, PROTARGA-P01-00-01, NCT00024401
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: THERADEX-P01-00-04, JHOC-01011003, PROTARGA-P01-00-04, NCT00024414
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 13 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01-04-22, NCT00244816
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 13 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01-04-21, NCT00249262
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01-05-23, NCT00422877
|
|
9.
|
Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01-02-17, NCT00087776
|